Super-Enhancers Dysregulations in Hematological Malignancies

Hematological malignancies affecting either the lymphoid or the myeloid lineages involve epigenetic mutations or dysregulation in the majority of cases. These epigenetic abnormalities can affect regulatory elements in the genome and, particularly, enhancers. Recently, large regulatory elements known...

Descripción completa

Detalles Bibliográficos
Autores principales: Belloucif, Yannis, Lobry, Camille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774084/
https://www.ncbi.nlm.nih.gov/pubmed/35053311
http://dx.doi.org/10.3390/cells11020196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774084/
https://www.ncbi.nlm.nih.gov/pubmed/35053311
http://dx.doi.org/10.3390/cells11020196

Ejemplares similares